Home › Funds › AXIOM INVESTORS LLC /DE › JNJ
AXIOM INVESTORS LLC /DE position in JNJ
JOHNSON & JOHNSON · Health Care
AXIOM INVESTORS LLC /DE reported holding 660,027 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$174.7M, representing 1.25% of its reported portfolio and ranking #19 among its reported holdings. AXIOM INVESTORS LLC /DE has disclosed JNJ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AXIOM INVESTORS LLC /DE's JNJ position evolved
AXIOM INVESTORS LLC /DE first disclosed a stake in JNJ in Q2 2026 at 491,072 shares (US$124.7M). The position peaked in Q3 2026 at 660,027 shares, worth US$174.7M. Across 2 filings, AXIOM INVESTORS LLC /DE increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 660,027 shares valued at US$174.7M — an increase of 168,955 shares quarter over quarter.. Notable position changes include a 34% increase in Q3 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 491.07K | $124.72M | New |
| Q3 2026 | 660.03K | $174.74M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JNJ and 13F data
JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JNJ
- BlackRock Inc 212.10M sh · $53.87B · Q2 2026
- Vanguard Group 240.35M sh · $49.74B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 157.76M sh · $41.76B · Q3 2026
- STATE STREET CORP 133.97M sh · $35.47B · Q3 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 65.65M sh · $17.38B · Q3 2026
- Geode Capital Management 65.50M sh · $17.30B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 59.09M sh · $14.97B · Q2 2026
- Morgan Stanley 44.81M sh · $11.38B · Q2 2026
- STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 31.59M sh · $8.36B · Q3 2026
- Norges Bank Investment Management 31.83M sh · $8.08B · Q2 2026
- Northern Trust Corp 28.79M sh · $7.31B · Q2 2026
- Capital World Investors 26.32M sh · $6.97B · Q3 2026
More on AXIOM INVESTORS LLC /DE
FAQ
How long has AXIOM INVESTORS LLC /DE held JNJ?
AXIOM INVESTORS LLC /DE has disclosed JNJ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is AXIOM INVESTORS LLC /DE's current position in JNJ?
As of Q3 2026, AXIOM INVESTORS LLC /DE holds 660.03K shares of JNJ (JOHNSON & JOHNSON), valued at $174.74M, representing 1.25% of its reported portfolio and ranking #19.
Has AXIOM INVESTORS LLC /DE been buying or selling JNJ?
In the latest 13F filing (Q3 2026), AXIOM INVESTORS LLC /DE increased its position in JNJ. The position peaked in Q3 2026 at 660.03K shares.
Which other funds hold JNJ?
Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.